Nerve growth factor inhibitor with novel‐binding domain demonstrates nanomolar efficacy in both cell‐based and cell‐free assay systems
Open Access
- 24 August 2017
- journal article
- research article
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 5 (5)
Abstract
Nerve growth factor (NGF), a member of the neurotrophin family, is known to regulate the development and survival of a select population of neurons through the binding and activation of the TrkA receptor. Elevated levels ofNGFhave been associated with painful pathologies such as diabetic neuropathy and fibromyalgia. However, completely inhibiting theNGFsignal could hold significant side effects, such as those observed in a genetic condition called congenital insensitivity to pain and anhidrosis (CIPA). Previous methods of screening forNGF‐inhibitors used labeling techniques which have the potential to alter molecular interactions.SPRspectroscopy andNGF‐dependent cellular assays were utilized to identify a novelNGF‐inhibitor,BVNP‐0197 (IC50 = 90 nmol/L), the firstNGF‐inhibitor described with a high nanomolarNGFinhibition efficiency. The present study utilizes molecular modeling flexible docking to identify a novel binding domain in the loopII/IVcleft ofNGF.Keywords
This publication has 43 references indexed in Scilit:
- Structural, biological, and pharmacological strategies for the inhibition of nerve growth factorNeurochemistry International, 2012
- Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee painOsteoarthritis and Cartilage, 2011
- Molecular and Structural Insight into proNGF Engagement of p75NTR and SortilinJournal of Molecular Biology, 2010
- Multipotent Neurotrophin Antagonist Targets Brain-Derived Neurotrophic Factor and Nerve Growth FactorThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Challenges in monoclonal antibody-based therapiesAnnals of Medicine, 2009
- Structural and Mechanistic Insights into Nerve Growth Factor Interactions with the TrkA and p75 ReceptorsNeuron, 2007
- High Affinity Not in the Vicinity?Neuron, 2007
- Endogenous NGF regulates CGRP expression in human monocytes, and affects HLA-DR and CD86 expression and IL-10 productionBlood, 2005
- Effect of blockade of nerve growth factor and tumor necrosis factor on pain behaviors after plantar incisionThe Journal of Pain, 2004
- The Role of Mast Cells in Inflammatory Processes: Evidence for Nerve/Mast Cell InteractionsInternational Archives of Allergy and Immunology, 1987